What was the overall market valuation of the US avian influenza-vaccine market in 2024?

The overall market valuation was $690.21 Million in 2024. Read More

What is the projected market valuation for the US avian influenza-vaccine market by 2035?

The projected valuation for 2035 is $1123.28 Million. Read More

What is the expected CAGR for the US avian influenza-vaccine market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 4.53%. Read More

Which companies are considered key players in the US avian influenza-vaccine market?

Key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, Ceva Santé Animale, Heska Corporation, Vetoquinol, Elanco Animal Health, and Virbac. Read More

What are the different types of vaccines available in the US avian influenza-vaccine market?

Types of vaccines include Live Attenuated, Inactivated, Recombinant, and Subunit Vaccines. Read More

What was the market value of Inactivated Vaccines in 2024?

The market value of Inactivated Vaccines was $250.0 Million in 2024. Read More

How much is the market for Waterborne vaccines projected to be by 2035?

The market for Waterborne vaccines is projected to reach $461.28 Million by 2035. Read More

What distribution channels are utilized for avian influenza vaccines in the US market?

Distribution channels include Veterinary Clinics, Online Pharmacies, and Retail Stores. Read More

What was the market value for Veterinary Clinics in 2024?

The market value for Veterinary Clinics was $345.1 Million in 2024. Read More

Which target species are primarily served by the US avian influenza-vaccine market?

Target species include Broilers, Layers, Breeders, and Backyard Poultry. Read More

What is the expected market size of the US Avian Influenza Vaccine Market in 2024?

In 2024, the US Avian Influenza Vaccine Market is expected to be valued at 680.4 million USD. Read More

What is the projected market value for the US Avian Influenza Vaccine Market by 2035?

By 2035, the US Avian Influenza Vaccine Market is anticipated to reach a total value of 1063.3 million USD. Read More

What is the estimated compound annual growth rate (CAGR) from 2025 to 2035 for this market?

The expected CAGR for the US Avian Influenza Vaccine Market from 2025 to 2035 is 4.142 percent. Read More

Which vaccine type is projected to have the highest market value in 2035?

In 2035, inactivated vaccines are projected to have the highest market value at 400.0 million USD. Read More

Which major players dominate the US Avian Influenza Vaccine Market?

Key players in the market include Zoetis, Merck Animal Health, and Elanco Animal Health among others. Read More

What are the expected values for live attenuated vaccines in the US Avian Influenza Vaccine Market by 2035?

Live attenuated vaccines are expected to reach a market value of 300.0 million USD by 2035. Read More

What percentage of the market is expected to be accounted for by recombinant vaccines by 2035?

Recombinant vaccines are anticipated to account for a market size of 225.0 million USD by 2035. Read More

How much is the subunit vaccines segment valued at in 2024?

In 2024, the subunit vaccines segment is valued at 80.4 million USD. Read More

What are the growth drivers for the US Avian Influenza Vaccine Market?

Increasing awareness of avian influenza and the need for biosecurity in poultry farming are key growth drivers. Read More

What challenges might impact the growth of the US Avian Influenza Vaccine Market from 2025 to 2035?

Challenges such as regulatory hurdles and potential market saturation may impact the growth of the market. Read More

US Avian Influenza Vaccine Market

ID: MRFR/Pharma/12280-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US Avian Influenza Vaccine Market Research Report: Size, Share, Trend Analysis By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines), By Administration Route (Intramuscular, Subcutaneous, Waterborne), By Target Species (Broilers, Layers, Breeders, Backyard Poultry) and By Distribution Channel (Veterinary Clinics, Online Pharmacies, Retail Stores) - Growth Outlook & Industry Forecast 2025 To 2035

US Avian Influenza Vaccine Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  1. 4.1.1 Live Attenuated Vaccines
  2. 4.1.2 Inactivated Vaccines
  3. 4.1.3 Recombinant Vaccines
  4. 4.1.4 Subunit Vaccines
2. 4.2 Food, Beverages & Nutrition, BY Administration Route (USD Million)
  1. 4.2.1 Intramuscular
  2. 4.2.2 Subcutaneous
  3. 4.2.3 Waterborne
3. 4.3 Food, Beverages & Nutrition, BY Target Species (USD Million)
  1. 4.3.1 Broilers
  2. 4.3.2 Layers
  3. 4.3.3 Breeders
  4. 4.3.4 Backyard Poultry
4. 4.4 Food, Beverages & Nutrition, BY Distribution Channel (USD Million)
  1. 4.4.1 Veterinary Clinics
  2. 4.4.2 Online Pharmacies
  3. 4.4.3 Retail Stores
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Boehringer Ingelheim (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck Animal Health (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Zoetis (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Ceva Santé Animale (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Heska Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Vetoquinol (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Elanco Animal Health (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Virbac (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY ADMINISTRATION ROUTE
4. 6.4 US MARKET ANALYSIS BY TARGET SPECIES
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Million)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY TARGET SPECIES, 2024 (% SHARE)
17. 6.17 FOOD, BEVERAGES & NUTRITION, BY TARGET SPECIES, 2024 TO 2035 (USD Million)
18. 6.18 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Million)
  3. 7.2.3 BY TARGET SPECIES, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

Live Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Subunit Vaccines

Food, Beverages & Nutrition By Administration Route (USD Million, 2025-2035)

Intramuscular
Subcutaneous
Waterborne

Food, Beverages & Nutrition By Target Species (USD Million, 2025-2035)

Broilers
Layers
Breeders
Backyard Poultry

Food, Beverages & Nutrition By Distribution Channel (USD Million, 2025-2035)

Veterinary Clinics
Online Pharmacies
Retail Stores

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”